ReviewHaematologica2025

Lessons learned from experience of phosphatidylinositol 3-kinase inhibitors in chronic lymphocytic leukemia and lymphoma.

Paola Ghione et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.